Rob Adam

Dr. Robert James Adam MA(Cantab) MBBS (London) PhD(UCL) FRACP FRCP (London) Behavioural neurologist with interests in cognition and movement disorders. Clinical lead for deep brain stimulation at The Royal Brisbane & Women's Hospital, Senior Lecturer and Clinical Trials Specialist at UQCCR. Movement disorders and advanced Parkinson's clinics in addition to Statewide Huntington's Disease, Friedreich's Ataxia and Metro North Deep Brain Stimulation services https://metronorth.health.qld.gov.au/news/deep-brain-stimulation-parkinsons. Young onset dementia clinic at STARS https://metronorth.health.qld.gov.au/stars/. Principal investigator in 2 Phase 1b/2a clinical trials of novel antisense oligonucleotides for Huntington's Disease, PRECISION-HD1 & 2 and their open label extensions. I am part of a nationwide and statewide effort to investigate drug repurposing - particularly in Parkinson's Disease. I collaborate widely in investigator led research with both clinical scientists, basic scientists and allied health practioners both at UQ and beyond. Former research officer in PISA (Prospective Imaging Study of Aging) https://www.qimrberghofer.edu.au/pisa/ and the clinical lead for ADNet in QLD. ADNet is an NHMRC funded project to screen and register patients with cognitive impairment https://www.australiandementianetwork.org.au/. I was trained in the US (NYU Medical Centre), UK (National Hospital for Neurology & Neurosurgery in Queen Square, UCLH, Cambridge University Hospitals) and Australia (Royal North Shore and Westmead Hospitals, Sydney). My PhD (UCL 2014) Thesis, "Dopamine and Oculomotor Decisions In Health & Disease", investigated the use of eye movement recordings during behavioral tasks to monitor decision making in patients with focal lesions, Parkinson's disease, impulse control disorders and healthy volunteers both under the influence and without the effects of dopaminergic modulators. I teach both medical undergraduates and graduates, supervise higher degree candidates and have written chapters in medical textbooks. Cognitive Neurology, Movement Disorders, Parkinson's Disease, Tremor, Dementia, Alzheimer's Disease, Huntington's Disease

[2026] A preliminary investigation of a Geriatric Depression Scale, Dementia version (GDS-D). Journal of Affective Disorders, 399 121056, 1-4. doi: 10.1016/j.jad.2025.121056 [2026] A mixed methods study exploring factors that impact physiotherapy participation for people with Parkinson’s disease. Disability and Rehabilitation, 48 (18), 5932-5944. doi: 10.1080/09638288.2026.2636395 [2026] Dopamine alters motor learning performance in the presence and absence of feedback. Neurobiology of Learning and Memory, 224 108140, 1-12. doi: 10.1016/j.nlm.2026.108140 [2026] Differentiating behavioural presentations of biomarker-confirmed Alzheimer’s disease from frontotemporal lobar degeneration using the Addenbrooke's Cognitive Examination-III. Dementia and Geriatric Cognitive Disorders, 1-17. doi: 10